Name: CLSI EP6 A : 1ED 2003
Brand: CLSI
Price: 273.60 USD

CLSI EP6 A : 1ED 2003

Superseded

View Superseded by

EVALUATION OF THE LINEARITY OF QUANTITATIVE MEASUREMENT PROCEDURES - A STATISTICAL APPROACH

Available format(s)

Hardcopy , PDF

Superseded date

06-10-2023

Language(s)

English

Published date

01-12-2013

Publisher

Clinical Laboratory Standards Institute

Covers guidelines for characterizing the linearity of a method during a method evaluation: for checking linearity as part of routine quality assurance: and for determining and stating a manufacture's claim for linear range.

DevelopmentNote	Supersedes NCCLS EP6 P2 (05/2003)
DocumentType	Miscellaneous Product
Pages	62
PublisherName	Clinical Laboratory Standards Institute
Status	Superseded
SupersededBy	CLSI EP06 ED2:2020
Supersedes	CLSI NRSCL8 P2 : 1993 CLSI EP6 P2 : 2ED 2001

CLSI GP31 P : 1ED 2007	LABORATORY INSTRUMENT IMPLEMENTATION, VERIFICATION, AND MAINTENANCE
CLSI EP32 R : 1ED 2006	METROLOGICAL TRACEABILITY AND ITS IMPLEMENTATION
CLSI H56 A : 1ED 2006	BODY FLUID ANALYSIS FOR CELLULAR COMPOSITION
CLSI EP19 : 2ED 2015	A FRAMEWORK FOR USING CLSI DOCUMENTS TO EVALUATE CLINICAL LABORATORY MEASUREMENT PROCEDURES
CLSI GP37 P : 1ED 2011	QUALITY MANAGEMENT SYSTEM: EQUIPMENT
CLSI H48 : 2ED 2016	DETERMINATION OF COAGULATION FACTOR ACTIVITIES USING THE ONE-STAGE CLOTTING ASSAY
CLSI EP18 A2 : 2ED 2009	RISK MANAGEMENT TECHNIQUES TO IDENTIFY AND CONTROL LABORATORY ERROR SOURCES
BS ISO 16142-2:2017	Medical devices. Recognized essential principles of safety and performance of medical devices General essential principles and additional specific essential principles for all IVD medical devices and guidance on the selection of standards
CLSI EP25 A : 1ED 2009	EVALUATION OF STABILITY OF IN VITRO DIAGNOSTIC REAGENTS
CLSI EP22 P : 1ED 2010	PRESENTATION OF A MANUFACTURER'S RISK MITIGATION INFORMATION FOR USERS OF IN VITRO DIAGNOSTIC DEVICES
CLSI C58 A : 1ED 2011	ASSESSMENT OF FETAL LUNG MATURITY BY THE LAMELLAR BODY COUNT
CLSI MM19 A : 1ED 2011	ESTABLISHING MOLECULAR TESTING IN CLINICAL LABORATORY ENVIRONMENTS
ISO 16142-2:2017	Medical devices — Recognized essential principles of safety and performance of medical devices — Part 2: General essential principles and additional specific essential principles for all IVD medical devices and guidance on the selection of standards
CLSI EP29 A : 1ED 2012	EXPRESSION OF MEASUREMENT UNCERTAINTY IN LABORATORY MEDICINE
CLSI H60 A : 1ED 2014	LABORATORY TESTING FOR THE LUPUS ANTICOAGULANT
CLSI POCT12 A3 : 3ED 2013	Point-of-Care Blood Glucose Testing in Acute and Chronic Care Facilities; Approved Guideline—Third Edition<br>
CLSI POCT9 A : 1ED 2010	SELECTION CRITERIA FOR POINT-OF-CARE TESTING DEVICES
CLSI MM1 A3 : 3ED 2012	MOLECULAR METHODS FOR CLINICAL GENETICS AND ONCOLOGY TESTING
CLSI POCT17 : 1ED 2016	USE OF GLUCOSE METERS FOR CRITICALLY ILL PATIENTS
CLSI EP18 P3 : 3ED 2009	RISK MANAGEMENT TECHNIQUES TO IDENTIFY AND CONTROL LABORATORY ERROR SOURCES
CLSI C51 P : 1ED 2010	EXPRESSION OF MEASUREMENT UNCERTAINTY IN LABORATORY MEDICINE
CLSI MM17 P : 1ED 2007	VERIFICATION AND VALIDATION OF MULTIPLEX NUCLEIC ACID ASSAYS
CLSI H26 P2 : 2ED 2009	VALIDATION, VERIFICATION, AND QUALITY ASSURANCE OF AUTOMATED HEMATOLOGY ANALYZERS
CLSI EP27 P : 1ED 2009	HOW TO CONSTRUCT AND INTERPRET AN ERROR GRID FOR DIAGNOSTIC ASSAYS
CLSI MM10 A : 1ED 2006	GENOTYPING FOR INFECTIOUS DISEASES: IDENTIFICATION AND CHARACTERIZATION
CLSI EP14 A3 : 2014	EVALUATION OF COMMUTABILITY OF PROCESSED SAMPLES
UNE-EN ISO 18113-1:2012	In vitro diagnostic medical devices - Information supplied by the manufacturer (labelling) - Part 1: Terms, definitions and general requirements (ISO 18113-1:2009)
CLSI MM5 A2 : 2ED 2012	NUCLEIC ACID AMPLIFICATION ASSAYS FOR MOLECULAR HEMATOPATHOLOGY
CLSI C24 : 4ED 2016	STATISTICAL QUALITY CONTROL FOR QUANTITATIVE MEASUREMENT PROCEDURES: PRINCIPLES AND DEFINITIONS
CLSI POCT9 P : 1ED 2009	SELECTION CRITERIA FOR POINT-OF-CARE TESTING DEVICES
CLSI I/LA32 P : 1ED 2009	NEWBORN SCREENING BY TANDEM MASS SPECTROMETRY
CLSI EP30 A : 1ED 2010	CHARACTERIZATION AND QUALIFICATION OF COMMUTABLE REFERENCE MATERIALS FOR LABORATORY MEDICINE
CLSI I/LA34 P : 1ED 2010	DESIGN AND VALIDATION OF IMMUNOASSAYS FOR ASSESSMENT OF HUMAN ALLERGENICITY OF NEW BIOTHERAPEUTIC DRUGS
CLSI MM6 A2 : 2ED 2010	QUANTITATIVE MOLECULAR METHODS FOR INFECTIOUS DISEASES
CLSI I/LA20 : 3ED 2016	ANALYTICAL PERFORMANCE CHARACTERISTICS, QUALITY ASSURANCE, AND CLINICAL UTILITY OF IMMUNOLOGICAL ASSAYS FOR HUMAN IMMUNOGLOBULIN E ANTIBODIES OF DEFINED ALLERGEN SPECIFICITIES
CLSI EP15 A2 : 2ED 2006	USER VERIFICATION OF PERFORMANCE FOR PRECISION AND TRUENESS
CLSI NBS04 A : 1ED 2010	NEWBORN SCREENING BY TANDEM MASS SPECTROMETRY<br>
CLSI C34 A3 : 3ED 2009	SWEAT TESTING: SAMPLE COLLECTION AND QUANTITATIVE CHLORIDE ANALYSIS
CLSI MM17 A : 1ED 2008	VERIFICATION AND VALIDATION OF MULTIPLEX NUCLEIC ACID ASSAYS
CLSI C53 P : 1ED 2008	CHARACTERIZATION AND QUALIFICATION OF COMMUTABLE REFERENCE MATERIALS FOR LABORATORY MEDICINE
I.S. EN ISO 18113-1:2011	IN VITRO DIAGNOSTIC MEDICAL DEVICES - INFORMATION SUPPLIED BY THE MANUFACTURER (LABELLING) - PART 1: TERMS, DEFINITIONS AND GENERAL REQUIREMENTS (ISO 18113-1:2009)
CLSI EP17 A2 : 2ED 2012	EVALUATION OF DETECTION CAPABILITY FOR CLINICAL LABORATORY MEASUREMENT PROCEDURES
CLSI QMS01 A4 : 4ED 2011	QUALITY MANAGEMENT SYSTEM: A MODEL FOR LABORATORY SERVICES
CLSI H26 A2 : 2ED 2010	VALIDATION, VERIFICATION, AND QUALITY ASSURANCE OF AUTOMATED HEMATOLOGY ANALYZERS
CLSI MM19 P : 1ED 2011	ESTABLISHING MOLECULAR TESTING IN CLINICAL LABORATORY ENVIRONMENTS
CLSI NBS05 A : 1ED 2011	NEWBORN SCREENING FOR CYSTIC FIBROSIS
CLSI I/LA20 A2 : 2ED 2009	ANALYTICAL PERFORMANCE CHARACTERISTICS AND CLINICAL UTILITY OF IMMUNOLOGICAL ASSAYS FOR HUMAN IMMUNOGLOBULIN E (IGE) ANTIBODIES AND DEFINED ALLERGEN SPECIFICITIES
CLSI MM10 P : 1ED 2005	GENOTYPING FOR INFECTIOUS DISEASES: IDENTIFICATION AND CHARACTERIZATION
CLSI C57 : 1ED 2015	MASS SPECTROMETRY FOR ANDROGEN AND ESTROGEN MEASUREMENTS IN SERUM
CLSI MM22 A : 1ED 2014	MICROARRAYS FOR DIAGNOSIS AND MONITORING OF INFECTIOUS DISEASES
CLSI EP36 : 1EDE 2015	HARMONIZATION OF SYMBOLOGY AND EQUATIONS
CLSI C50 P : 1ED 2007	MASS SPECTROMETRY IN THE CLINICAL LABORATORY: GENERAL PRINCIPLES AND GUIDANCE
ISO 18113-1:2009	In vitro diagnostic medical devices — Information supplied by the manufacturer (labelling) — Part 1: Terms, definitions and general requirements
EN ISO 18113-1:2011	In vitro diagnostic medical devices - Information supplied by the manufacturer (labelling) - Part 1: Terms, definitions and general requirements (ISO 18113-1:2009)
CLSI EP18 P2 : 2ED 2007	RISK MANAGEMENT TECHNIQUES TO IDENTIFY AND CONTROL LABORATORY ERROR SOURCES
CLSI H56 P : 1ED 2005	BODY FLUID ANALYSIS FOR CELLULAR COMPOSITION
CLSI QMS13 A : 1ED 2011	QUALITY MANAGEMENT SYSTEM: EQUIPMENT
CLSI EP9 A3 : 3ED 2013	MEASUREMENT PROCEDURE COMPARISON AND BIAS ESTIMATION USING PATIENT SAMPLES
CLSI MM16 A : 1ED 2006	USE OF EXTERNAL RNA CONTROLS IN GENE EXPRESSION ASSAYS
DIN EN ISO 18113-1:2013-01	IN VITRO DIAGNOSTIC MEDICAL DEVICES - INFORMATION SUPPLIED BY THE MANUFACTURER (LABELLING) - PART 1: TERMS, DEFINITIONS AND GENERAL REQUIREMENTS (ISO 18113-1:2009)
BS EN ISO 18113-1:2011	In vitro diagnostic medical devices. Information supplied by the manufacturer (labelling) Terms, definitions and general requirements
CLSI C50 A : 1ED 2007	MASS SPECTROMETRY IN THE CLINICAL LABORATORY: GENERAL PRINCIPLES AND GUIDANCE
ANSI/AAMI/ISO 16142-2:2017	MEDICAL DEVICES - RECOGNIZED ESSENTIAL PRINCIPLES OF SAFETY AND PERFORMANCE OF MEDICAL DEVICES - PART 2: GENERAL ESSENTIAL PRINCIPLES AND ADDITIONAL SPECIFIC ESSENTIAL PRINCIPLES FOR ALL IVD MEDICAL DEVICES AND GUIDANCE ON THE SELECTION OF STANDARDS
CLSI C43 A2 : 2ED 2010	GAS CHROMATOGRAPHY/MASS SPECTROMETRY CONFIRMATION OF DRUGS
UNI EN ISO 18113-1 : 2012	IN VITRO DIAGNOSTIC MEDICAL DEVICES - INFORMATION SUPPLIED BY THE MANUFACTURER (LABELLING) - PART 1: TERMS, DEFINITIONS AND GENERAL REQUIREMENTS
CLSI EP15 A3 : 3ED 2014	USER VERIFICATION OF PRECISION AND ESTIMATION OF BIAS